116 related articles for article (PubMed ID: 17926899)
1. [Angina pectoris in patients who underwent stent implantations for severe atherosclerotic coronary lesions 16 years after heart transplantation].
Yamada A; Ishii Y; Kakizawa Y; Ishige A; Ueno H; Omichi C; Tanaka T; Nagashima H; Kanmatsuse K; Endo M
Kyobu Geka; 2007 Oct; 60(11):969-73. PubMed ID: 17926899
[TBL] [Abstract][Full Text] [Related]
2. [Angina after a heart transplant with evidence of late sympathetic reinnervation. Report of one case].
Riedemann S E; Castro G P; Quintana F JC; Pérez P O; Mc-Nab M P
Rev Med Chil; 2007 Dec; 135(12):1577-81. PubMed ID: 18357360
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
4. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
9. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ
Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549
[TBL] [Abstract][Full Text] [Related]
10. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW;
J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266
[TBL] [Abstract][Full Text] [Related]
11. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.
Benza RL; Zoghbi GJ; Tallaj J; Brown R; Kirklin JK; Hubbard M; Rayburn B; Foley B; McGiffin DC; Pinderski LJ; Misra V; Bourge RC
J Am Coll Cardiol; 2004 Jun; 43(11):1973-81. PubMed ID: 15172400
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.
Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A
J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
15. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
Buszman P; Trznadel S; Zurakowski A; Milewski K; Kinasz L; Król M; Kondys M
Kardiol Pol; 2007 Sep; 65(9):1041-6; discussion 1047-8. PubMed ID: 17975751
[TBL] [Abstract][Full Text] [Related]
16. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
Yarkoni A; Brodsky A; Sabapathy R; Pershad A
Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
[TBL] [Abstract][Full Text] [Related]
17. Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
Aqel RA; Wells BJ; Hage FG; Tallaj J; Benza R; Pamboukian S; Rayburn B; McGiffin D; Kirklin J; Bourge R
J Heart Lung Transplant; 2008 Jun; 27(6):610-5. PubMed ID: 18503959
[TBL] [Abstract][Full Text] [Related]
18. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
20. Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up.
Ho PC; Nguyen ME
J Invasive Cardiol; 2008 Jan; 20(1):41-3. PubMed ID: 18174619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
